2022 BRACE Award Venture Competition

The Asian Fund for Cancer Research congratulates our five semi-finalists of the 2022 BRACE Award Venture Competition. The BRACE Award aims to provide vital support to early-stage biotechs, enabling them to accelerate their innovative therapeutics, diagnostics and cancer prevention products into the clinic, with the ultimate goal of improving outcomes for patients affected by cancer globally.

The winner of the 2022 BRACE Award Venture Competition will receive up to US$600,000 from AFCR and co-investors, which will allow the startup to pursue proof of concept and proof of value on the path to clinical trials and, eventually, to new effective cancer technologies that could save patients’ lives.